CASP3 and neoplasm: Low-dose cGAMP significantly increased the production of IL-12 by MDSCs, with improved T lymphocyte responses to MAGE-b, whereas a high dose of cGAMP activated caspase-3 in the 4T1 tumor cells and killed the tumor cells directly.